BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29128909)

  • 1. Central noradrenergic activity affects analgesic effect of Neuropeptide S.
    Jinushi K; Kushikata T; Kudo T; Calo G; Guerrini R; Hirota K
    J Anesth; 2018 Feb; 32(1):48-53. PubMed ID: 29128909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive effects of neurotropin in a rat model of central neuropathic pain: DSP-4 induced noradrenergic lesion.
    Kudo T; Kushikata T; Kudo M; Kudo T; Hirota K
    Neurosci Lett; 2011 Sep; 503(1):20-2. PubMed ID: 21843596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A central neuropathic pain model by DSP-4 induced lesion of noradrenergic neurons: preliminary report.
    Kudo T; Kushikata T; Kudo M; Kudo T; Hirota K
    Neurosci Lett; 2010 Sep; 481(2):102-4. PubMed ID: 20599586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of coerulean noradrenergic neurones in general anaesthesia in rats.
    Kushikata T; Yoshida H; Kudo M; Kudo T; Kudo T; Hirota K
    Br J Anaesth; 2011 Dec; 107(6):924-9. PubMed ID: 21965049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
    Fritschy JM; Grzanna R
    Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional recovery of locus coeruleus noradrenergic neurons after DSP-4 lesion: effects on dopamine levels and neuroleptic induced-parkinsonian symptoms in rats.
    Srinivasan J; Schmidt WJ
    J Neural Transm (Vienna); 2004 Jan; 111(1):13-26. PubMed ID: 14714212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated Administration of Amitriptyline in Neuropathic Pain: Modulation of the Noradrenergic Descending Inhibitory System.
    Hiroki T; Suto T; Saito S; Obata H
    Anesth Analg; 2017 Oct; 125(4):1281-1288. PubMed ID: 28787345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
    Fritschy JM; Grzanna R
    Prog Brain Res; 1991; 88():257-68. PubMed ID: 1726027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia.
    Sawynok J; Reid A
    Brain Res; 1987 Sep; 419(1-2):156-65. PubMed ID: 3119144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
    Harro J; Jossan SS; Oreland L
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic modulation of gonadotrophin-inhibitory hormone gene expression in the brain of Japanese quail.
    Tobari Y; Kansaku N; Tsutsui K
    J Neuroendocrinol; 2017 Aug; 29(8):. PubMed ID: 28683170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the analgesic effect of morphine on models of acute nociceptive pain in rats with a central noradrenergic system lesion.
    Roczniak W; Oswiecimska JM; Brodziak-Dopierala B; Cipora E; Nowak PG; Babuska-Roczniak M
    Neuro Endocrinol Lett; 2016 Jul; 37(3):239-244. PubMed ID: 27618597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central noradrenergic lesion induced by DSP-4 impairs the acquisition of avoidance reactions and prevents molecular changes in the amygdala.
    Radwanska K; Nikolaev E; Kaczmarek L
    Neurobiol Learn Mem; 2010 Oct; 94(3):303-11. PubMed ID: 20650329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of central noradrenergic system lesion on the serotoninergic 5-HT3 receptor mediated analgesia in rats.
    Roczniak W; Wróbel J; Dolczak L; Nowak P
    Adv Clin Exp Med; 2013; 22(5):629-38. PubMed ID: 24285447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal DSP-4 treatment modifies antinociceptive effects of the CB1 receptor agonist methanandamide in adult rats.
    Korossy-Mruk E; Kuter K; Nowak P; Szkilnik R; Rykaczewska-Czerwinska M; Kostrzewa RM; Brus R
    Neurotox Res; 2013 Jan; 23(1):39-48. PubMed ID: 22488162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain.
    Fritschy JM; Grzanna R
    J Comp Neurol; 1992 Jul; 321(3):421-41. PubMed ID: 1506478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat.
    Szot P; Miguelez C; White SS; Franklin A; Sikkema C; Wilkinson CW; Ugedo L; Raskind MA
    Neuroscience; 2010 Mar; 166(1):279-91. PubMed ID: 20045445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of locus coeruleus projections in opiate withdrawal but not in opiate tolerance in mice.
    Dossin O; Hanoun N; Zajac JM
    Eur J Pharmacol; 1996 Jul; 308(3):271-4. PubMed ID: 8858297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by R(-)-deprenyl and N-2-hexyl-N-methylpropargylamine on DSP-4, a neurotoxin, induced degeneration of noradrenergic neurons in the rat locus coeruleus.
    Zhang X; Zuo DM; Yu PH
    Neurosci Lett; 1995 Feb; 186(1):45-8. PubMed ID: 7540268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenergic-serotonergic interactions and nociception in the rat.
    Archer T; Jonsson G; Minor BG; Post C
    Eur J Pharmacol; 1986 Jan; 120(3):295-307. PubMed ID: 3081358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.